Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch, Ludo Lavreys, Merlin L. Robb et al.|The Lancet|2018Cited by 342
Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy AdultsFrances Priddy, Deborah D. Brown, James G. Kublin et al.|Clinical Infectious Diseases|2008Cited by 246
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phasesLindsey R. Baden, Jacqueline M. Miller, Hana M. El Sahly et al.|Nature Communications|2024Cited by 35